A detailed history of Ronald Blue Trust, Inc. transactions in Compass Pathways PLC stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 261 shares of CMPS stock, worth $2,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
261
Previous 13,368 98.05%
Holding current value
$2,228
Previous $114,000 98.25%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
N/A
-13,107 Reduced 98.05%
261 $2,000
Q2 2024

Jul 18, 2024

BUY
N/A
13,368 New
13,368 $114,000
Q4 2023

Jan 18, 2024

BUY
N/A
49 New
49 $0
Q2 2023

Jul 14, 2023

BUY
$7.79 - $10.69 $31 - $42
4 New
4 $0
Q4 2022

Jan 17, 2023

BUY
$7.84 - $11.68 $133 - $198
17 Added 26.15%
82 $1,000
Q3 2022

Oct 21, 2022

BUY
$10.73 - $20.07 $697 - $1,304
65 New
65 $1,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.